Fundz

Garland Surgical closes €3.5M seed round led by Ferghana Partners, to fund clinical studies and advance preparations for Series A financing.

PRIVATEMay 19, 2026

Amount Raised

€3.5 Million

Round Type

Seed

WorcesterBiotechnologyHealth CareMedicalMedical Device

Investors

Malta EnterpriseFerghana Partners

Description

Garland Surgical Ltd successfully closed its €3.5 million seed funding round, consisting of €2.1 million in equity and €1.4 million in grants. The funding will support product development and regulatory preparation for their TriActiv Hip™ system. Following this, the company is gearing up for Series A financing. Ferghana Partners is backing this next stage, aimed at making regulatory submissions and funding clinical studies.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Garland Surgical Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Biobot Surgical raised $15M (Funding Round) on June 29, 2026.
  • PreTel raised $50K (Seed) on June 28, 2026.
  • Magdent raised $150K (Pre-Seed) on June 26, 2026.
  • Grail raised $110M (Post-IPO Equity) on June 25, 2026.
  • Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
  • Kinomatic raised $4M (Seed) on June 18, 2026.

Who to call at Garland Surgical Ltd, and when

A new round usually means Garland Surgical Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Garland Surgical Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Garland Surgical Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Garland Surgical Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Garland Surgical Ltd

Location

Worcester, England, United Kingdom

About

Garland Surgical Ltd is a UK-based orthopaedic medical device company focused on developing the TriActiv Hip, a patented next-generation triaxial hip system. The company aims to disrupt the hip replacement market by providing a novel solution that enhances mobility, stability, and durability. With ongoing support through funding, Garland is preparing for regulatory submissions and clinical studies to unlock the commercial potential of its product. Their innovation addresses the needs of diverse and active patient populations, particularly those at higher risk of hip dislocation and instability.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Garland Surgical Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Garland Surgical Ltd's next move

See what Strategic adds

Garland Surgical Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.